NCT07551414 clinical trial report covering Zorifertinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07692867 clinical trial report covering Tononadif Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07690761 clinical trial report covering Zanubrutinib, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

ChiCTR2600127842 clinical trial report covering Budesonide, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07702474 clinical trial report covering Chitosan, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07550231 clinical trial report covering AD-211, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

Clinuvel Pharmaceuticals Limited 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Codagenix, Inc. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Cognition Therapeutics, Inc. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

CombiGene AB (publ) 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Cleave Therapeutics, Inc. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Chongqing Zhifei Biological Products Co., Ltd. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.